Home/Rare Diseases/Ehrlichiosis

Tick-Borne & Infectious

Ehrlichiosis (HME) Clinical Trials and Treatments

Also called Human monocytic ehrlichiosis, HME, Ehrlichia chaffeensis infection, Ehrlichia ewingii infection, Ehrlichia muris eauclairensis infection

Ehrlichiosis is caused by Ehrlichia bacteria that live inside white blood cells. In the United States the main cause is Ehrlichia chaffeensis, with smaller numbers from Ehrlichia ewingii.

View 0 active trialsMatch me to a trial

About Ehrlichiosis

Ehrlichiosis is caused by Ehrlichia bacteria that live inside white blood cells. In the United States the main cause is Ehrlichia chaffeensis, with smaller numbers from Ehrlichia ewingii. Both spread through the bite of the lone star tick (Amblyomma americanum), which is found across the South, Midwest and East Coast and is spreading north. A third species, Ehrlichia muris eauclairensis, is carried by the blacklegged tick and has only been reported in Wisconsin and Minnesota and in people who traveled there. Ehrlichiosis is a close cousin of anaplasmosis, which is caused by a related bacterium carried by the blacklegged tick; the 2 illnesses look alike and are treated the same way.

Most people have a mild or moderate illness, but ehrlichiosis can be severe, with brain involvement in about 1 in 5 severe cases, bleeding problems and organ failure. The CDC says doxycycline is the first-line treatment for adults and children of all ages, and that treatment should never be delayed or withheld while waiting for lab results. Fever usually breaks within 24 to 48 hours of starting it, and that quick response is itself a clue the diagnosis was right. The usual adult dose is 100 mg twice a day for at least 5 to 7 days and until 72 hours after the fever is gone.

Testing is best done with PCR on a blood sample in the first week of illness; antibody tests often turn positive only later, so a negative early test does not rule the infection out. The CDC does not recommend taking antibiotics to prevent ehrlichiosis after a tick bite, and there is no vaccine. Columbia University's Lyme and Tick-Borne Diseases Research Center and Johns Hopkins both list ehrlichiosis among the infections to consider when someone with a tick bite has fever, low platelets or abnormal liver tests.

Common Symptoms of Ehrlichiosis

Recognizing the signs of Ehrlichiosis early can lead to faster diagnosis and better outcomes. Symptoms may vary in severity from person to person. If you or a loved one are experiencing any of the following, consider speaking with a specialist.

  • Fever and chills, usually 5 to 14 days after a tick bite
  • Severe headache and muscle aches
  • Nausea, vomiting, diarrhea or loss of appetite
  • A rash, in up to 60% of children but fewer than 30% of adults
  • Low white blood cells and platelets, and raised liver enzymes on blood tests
  • Confusion or other brain involvement in severe cases

Who Ehrlichiosis Affects

Anyone bitten by an infected tick, most often in states where the lone star tick is common. Severe illness is more likely in children under 5, adults over 65, people with weakened immunity from advanced HIV, chemotherapy or immune-suppressing drugs, and anyone whose treatment is delayed. Ehrlichia has also spread, rarely, through blood transfusion and organ transplant.

Find Your Next Step

Answer a few questions and we'll point you to the right tools and information for where you are right now.

Where are you in your Ehrlichiosis journey?

FDA-Approved Treatments for Ehrlichiosis

There is currently 1 FDA-approved medication for Ehrlichiosis. These therapies represent the current standard of care and may be used alongside or compared against investigational treatments in active clinical trials.

Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.

Ask about these treatments
Answers with sources, in plain English
Start withor ask

Help Paying for Ehrlichiosis Treatment

Charity funds and drugmaker programs for Ehrlichiosis, checked at the source.

Which insurance do you have? Pick one to see what fits. Tap it again to clear.
Your insurance
Drugmaker programs
Open a medicine for who qualifies, by insurance type.

Open the full patient assistance finder →

Side Effect Explorer

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Questions about side effects?
I can help you understand what these reports mean
Start withor ask

Diagnosis and Testing

Tick-borne bacterial infection (Ehrlichia chaffeensis or related species), diagnosed by PCR or antibody tests; not genetic.

Trusted Ehrlichiosis Resources

Reputable organizations and medical references for learning more about Ehrlichiosis, including disease registries, foundation resources, and clinical guidelines.

Active Clinical Trials for Ehrlichiosis

This Ehrlichiosis clinical trial finder lists studies as they become available, with eligibility criteria in plain English. These studies play a critical role in advancing care for tick-borne & infectious conditions and may offer access to treatments not yet widely available. Each trial below is sourced directly from ClinicalTrials.gov, with eligibility criteria translated into plain English to help patients and caregivers evaluate whether a study may be a fit.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

No active clinical trials yet

Ehrlichiosis is a classified rare disease, but clinical trial activity for it is limited. That's part of why we track it. When a trial opens, Trial Friend will have it.

Get notified the moment a Ehrlichiosis trial is registered on ClinicalTrials.gov.

Get Ehrlichiosis alerts by email

One email when something new happens for Ehrlichiosis, never a newsletter.

You'll get new recruiting trials, changes to trials, FDA decisions and condition news for Ehrlichiosis. Turn any of these off from the link in every email.

We never share your email. Unsubscribe anytime. Privacy policy

Patient Communities

Connect with other Ehrlichiosis patients, caregivers, and advocacy groups across Facebook groups, Reddit communities, and YouTube channels. These patient communities offer peer support, shared experiences, caregiver resources, and real-time discussion about Ehrlichiosis treatments, clinical trial participation, and day-to-day disease management.

Find the right community
Answers with sources, in plain English
Start withor ask

Related Tick-Borne & Infectious Conditions

Other rare diseases in the tick-borne & infectious category. Patients with Ehrlichiosis may find relevant research, shared treatment pathways, or overlapping clinical trials among these related conditions.

Frequently Asked Questions About Ehrlichiosis